Latest Articles

This article examines how physical activity and exercise influence cancer prevention, mitigate treatment-related side effects, enhance quality of life and impact overall mortality in oncology patients.

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based approaches, highlighting their expanding clinical use, underlying mechanisms and the challenges that lie ahead.

Dr. John Beeler, BPGbio, discusses why investing in biology is essential for AI-driven drug discovery and for building a more sustainable, cost-effective healthcare system worldwide.

In the era of precision oncology, the integration of high-throughput, multimodal datasets presents both a formidable challenge and a transformative opportunity. We spoke to Dr. Benjamin Haibe-Kains about how AI/ML data models are helping.

Dr. Jennifer Man, director of Science at UK Biocentre, explains why biological sample storage must evolve to prevent costly research losses and meet new regulations with automated, climate-friendly systems.

You can’t clean up what you can’t detect, whether it’s dealing with the aftermath of a chemical spill or checking food for adulteration. Find out how spatially offset Raman spectroscopy is a game-changer in non-invasive chemical characterization.

This article explores some of the reasons animal models are used in neuroscience and how this could change in the future.

Metabolomics is expected to increasingly impact precision medicine and diagnostics.

While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto Watamura could be vital.

Dr. Majid Keshavarz, chief technical officer of the battery producer Enervenue, tells Technology Networks how his team is commercializing a long-overlooked NASA battery technology for grid-scale applications.